Download 6115/01 Edexcel GCE

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Amino acid synthesis wikipedia , lookup

Metabolism wikipedia , lookup

Blood type wikipedia , lookup

Biosynthesis wikipedia , lookup

Hemorheology wikipedia , lookup

Blood sugar level wikipedia , lookup

Ketosis wikipedia , lookup

Biochemistry wikipedia , lookup

Cyanobacteria wikipedia , lookup

Transcript
Surname
Centre
No.
Initial(s)
Paper Reference
6 1 1 5
Candidate
No.
0 1
Signature
Paper Reference(s)
6115/01
Examiner’s use only
Edexcel GCE
Team Leader’s use only
Biology (Human)
Advanced
Unit 5H
Question Leave
Number Blank
Friday 13 June 2008 – Afternoon
Time: 1 hour 30 minutes
1
2
3
4
5
Materials required for examination
Ruler
Items included with question papers
Nil
6
7
8
Instructions to Candidates
In the boxes above, write your centre number, candidate number, your surname, initial(s) and
signature.
The paper reference is shown above. Check that you have the correct question paper.
Answer ALL EIGHT questions in the spaces provided in this booklet.
Show all the steps in any calculations and state the units. Calculators may be used.
Include diagrams in your answers where these are helpful.
Information for Candidates
The marks for individual questions and parts of questions are shown in round brackets: e.g. (2).
The total mark for this question paper is 70.
Advice to Candidates
You will be assessed on your ability to organise and present information, ideas, descriptions and
arguments clearly and logically, taking account of your use of grammar, punctuation and spelling.
The Synoptic section (Questions 4 to 7) is designed to give you the opportunity to make connections
between different areas of biology and to use skills and ideas developed throughout the course in
new contexts. You should include in your answers any relevant information from the whole of your
course.
Total
This publication may be reproduced only in accordance with
Edexcel Limited copyright policy.
©2008 Edexcel Limited.
Printer’s Log. No.
H30911A
W850/R6115/57570 8/7/7/3/1
Turn over
*H30911A0120*
Leave
blank
Answer ALL questions in the spaces provided.
1.
If a horse, Equus caballus, is mated with a donkey, Equus asinus, a hybrid known as a
mule is produced.
Horse
(Equus caballus)
2n = 64
×
Donkey
(Equus asinus)
2n = 62
Mule
Mules are almost always sterile and produce no offspring. This phenomenon is an example
of a post-zygotic isolating mechanism.
(a) State the diploid number of chromosomes in a mule and suggest why mules are
unable to produce offspring.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
2
*H30911A0220*
Leave
blank
(b) State what is meant by the term isolating mechanism. Suggest why the production
of a mule by mating a horse with a donkey is described as a post-zygotic isolating
mechanism.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
(c) It has been suggested that the mule should be named as a new species, Equus mulus.
Suggest why this might not be acceptable to some biologists.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(2)
Q1
(Total 8 marks)
*H30911A0320*
3
Turn over
Leave
blank
2.
Immunological studies of blood sera can be used as evidence for the ancestral relationship
between modern humans and the great apes.
The diagram below shows some of the stages in the process used to compare human blood
serum with that of some of the modern great apes.
STAGE A
Human blood serum
injected into rabbit
STAGE B
Sensitised serum
prepared from
rabbit’s blood
STAGE C
Sensitised serum
mixed with test
serum from ape
STAGE D
Degree of
precipitation
assessed
(a) Explain what happens in the blood of the rabbit following the injection of human
blood serum at stage A.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(2)
4
*H30911A0420*
Leave
blank
(b) The table below shows the relative degree of precipitation at stage D, following the
mixing of sensitised serum with test serum from humans and apes at stage C.
Serum sample
Relative degree of precipitation
Human
+++++
Chimpanzee
++++
Gibbon
++
Gorilla
++++
Orang-utan
+++
Suggest why the sensitised serum was tested using a sample of human serum.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(1)
(c) Explain why the results support the idea that humans had common ancestry with
gorillas and chimpanzees more recently than with gibbons or orang-utans.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
Q2
(Total 6 marks)
*H30911A0520*
5
Turn over
Leave
blank
3.
The diagrams below show population pyramids for Uganda and the USA for the year 2000
and the estimates for the year 2025.
Population pyramids for Uganda and the USA in year 2000
Uganda: 2000
MALE
FEMALE
Ages
80+
75–79
70–74
65–69
60–64
55–59
50–54
45–49
40–44
35–39
30–34
25–29
20–24
15–19
10–14
5–9
0–4
12
10
8
6
4
2
0
0
2
Population (in millions)
4
6
8
10
12
The USA: 2000
MALE
FEMALE
Ages
80+
75–79
70–74
65–69
60–64
55–59
50–54
45–49
40–44
35–39
30–34
25–29
20–24
15–19
10–14
5–9
0–4
12
6
10
8
6
4
2
0
0
2
Population (in millions)
4
6
*H30911A0620*
8
10
12
Leave
blank
Population pyramids (estimated) for Uganda and the USA in year 2025
Uganda: 2025
MALE
FEMALE
Ages
80+
75–79
70–74
65–69
60–64
55–59
50–54
45–49
40–44
35–39
30–34
25–29
20–24
15–19
10–14
5–9
0–4
12
10
8
6
4
2
0
0
2
Population (in millions)
4
6
8
The USA: 2025
Ages
MALE
10
12
FEMALE
80+
75–79
70–74
65–69
60–64
55–59
50–54
45–49
40–44
35–39
30–34
25–29
20–24
15–19
10–14
5–9
0–4
12
10
8
6
4
2
0
0
2
Population (in millions)
4
6
8
10
12
Source: U.S. Census Bureau, International Data Base
*H30911A0720*
7
Turn over
Leave
blank
(a) Explain what is shown by a population pyramid.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(2)
(b) (i) With reference to the year 2000, explain what the data indicate about life
expectancy in the USA compared with that in Uganda.
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
(3)
(ii) Give two reasons why the life expectancy may differ in the two countries.
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
(2)
8
*H30911A0820*
Leave
blank
(c) Compare the changes estimated for Uganda between the years 2000 and 2025 with
those shown for the USA.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
Q3
(Total 10 marks)
*H30911A0920*
9
Turn over
Leave
blank
Synoptic Section
The questions in this section are designed to give you the opportunity to make connections
between different areas of biology and to use skills and ideas developed throughout the course
in new contexts. You should include in your answers any relevant information from the whole
of your course.
4.
In summer, algal blooms are a common sight on ponds and lakes. One type of algal bloom
is caused by cyanobacteria. The cyanobacteria release poisonous chemicals that can kill
animals that drink the water.
(a) Cyanobacteria are prokaryotes. In the space below, draw a diagram of a typical
prokaryotic cell. On your drawing, label the following four structures: cell wall, cell
surface (plasma) membrane, flagellum and plasmid.
(4)
(b) Under normal conditions, the numbers of cyanobacteria in a lake are controlled
by zooplankton (microscopic animals) and fish. A typical food chain involving
cyanobacteria is shown below.
Cyanobacteria
Zooplankton
Small fish
Large fish
Explain how a sudden increase in the level of nitrates in the lake could disrupt this
food chain.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
10
*H30911A01020*
Leave
blank
(c) The numbers of cyanobacteria can be controlled by using mats of barley straw which
float on the water. The barley straw releases growth inhibitors. Suggest how these
inhibitors could interfere with the growth of the cyanobacteria.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(2)
(d) It may be possible to reduce the numbers of cyanobacteria by introducing predators
or parasites of the cyanobacteria. Suggest one reason why it would be preferable to
use biological control, rather than chemical control, to reduce the cyanobacteria.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(1)
Q4
(Total 10 marks)
*H30911A01120*
11
Turn over
Leave
blank
5.
The photograph below shows two blood vessels, as seen using a light microscope.
A



Magnification ×50
(a) (i) Identify the type of blood vessel labelled A on the photograph.
................................................................................................................................
(1)
(ii) Describe two features of blood vessel A and explain the function of each
feature.
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
................................................................................................................................
(4)
12
*H30911A01220*
Leave
blank
(b) People suffering from high blood pressure may be given Angiotensin Converting
Enzyme (ACE) inhibitors. The ACE inhibitor stops the conversion of an inactive
substance in the blood called angiotensin I to the active form, angiotensin II.
Angiotensin II causes blood vessels to constrict.
Suggest how the ACE inhibitor could prevent the conversion of angiotensin I to
angiotensin II.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(4)
Q5
(Total 9 marks)
*H30911A01320*
13
Turn over
BLANK PAGE
14
*H30911A01420*
Leave
blank
6.
The polypeptide hormone, insulin, is involved in the regulation of blood glucose levels in
mammals. Human insulin is composed of two chains of amino acids. Chain A consists
of 21 amino acids and Chain B of 30 amino acids. The chains are held together by two
disulphide bridges (S2 and S3). A third disulphide bridge (S1) is present within the A
chain.
The diagram below shows the structure of human insulin. Each three-letter code in
Chain A and Chain B represents an amino acid. S1, S2 and S3 show the three disulphide
bridges.
Gly



Ile


Val
 Chain A


Glu
S1


Gln–Cys–Cys–Thr–Ser–Ile–Cys–Ser–Leu–Tyr–Gln–Leu–Glu–Asn–Tyr–Cys–Asn 
S2
S3
His–Leu–Cys–Gly–Ser–His–Leu–Val–Glu–Ala–Leu–Tyr–Leu–Val–Cys



Gly
Gln


Glu
Asn
 Chain B


Arg
Val



Phe
Thr–Lys–Pro–Thr–Tyr–Phe–Phe–Gly
Box T
(a) Explain how the amino acids, isoleucine (Ile), valine (Val) and glutamic acid (Glu),
shown in Box T, are linked together.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(2)
*H30911A01520*
15
Turn over
Leave
blank
(b) Chain A and Chain B are held together by disulphide bridges, a type of covalent bond.
Give examples of two other types of bond that may be found between polypeptide
chains. State how the relative strength of these bonds compares with that of disulphide
bridges.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(3)
(c) In an investigation a student, who had not eaten for 12 hours, drank a solution
containing 100 g of glucose. The level of glucose in the blood of the student was
then monitored for the next 4 hours. The graph below shows the results of the
investigation.
10
9
8
7
Blood glucose /
mmol per dm3
of blood
6
5
4
3
2
1
0
16
0
1
2
Time / hours
3
*H30911A01620*
4
Leave
blank
Suggest why the level of glucose in the blood of the student started to rise within the
first hour after drinking the solution.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(1)
(d) A point mutation may lead to the replacing of the amino acid, cysteine (Cys), with
another amino acid during the production of insulin. The resulting insulin would have
a different structure. Suggest how the results of the investigation would have differed
had the student used this insulin. Explain your answer.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(6)
Q6
(Total 12 marks)
*H30911A01720*
17
Turn over
Leave
blank
7.
The diagram below shows a rod cell from the retina of the human eye.








Inner

segment 








Connecting pair
of cilia





Outer

segment 






End bulb
Nucleus
Mitochondrion
Vesicles
(containing
photosensitive
pigments)
The function of rod cells can be affected by the condition known as retinitis pigmentosa.
Retinitis pigmentosa causes the gradual breakdown of photoreceptor cells in the retina. As
these cells degenerate and die, patients experience progressive loss of vision.
One of the most common forms of retinitis pigmentosa can be caused by a recessive allele
inherited from parents who have normal vision.
18
*H30911A01820*
Leave
blank
(a) With reference to the function of rod cells and rhodopsin as photoreceptors, explain
why people with retinitis pigmentosa experience progressive loss of vision.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(4)
(b) Two parents with normal vision have a child who develops retinitis pigmentosa. With
the aid of a genetic diagram, explain the probability of the disorder developing in any
future children they have.
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
.......................................................................................................................................
(5)
Q7
(Total 9 marks)
*H30911A01920*
19
Turn over
Leave
blank
8.
Describe three uses of lipids in humans.
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
(Total 6 marks)
TOTAL FOR PAPER: 70 MARKS
END
20
*H30911A02020*
Q8